AU2008213772A1 - Composition comprising terpene compounds and methods for inhibiting nerve transmission - Google Patents

Composition comprising terpene compounds and methods for inhibiting nerve transmission Download PDF

Info

Publication number
AU2008213772A1
AU2008213772A1 AU2008213772A AU2008213772A AU2008213772A1 AU 2008213772 A1 AU2008213772 A1 AU 2008213772A1 AU 2008213772 A AU2008213772 A AU 2008213772A AU 2008213772 A AU2008213772 A AU 2008213772A AU 2008213772 A1 AU2008213772 A1 AU 2008213772A1
Authority
AU
Australia
Prior art keywords
composition
unbranched
dimethyl
group
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008213772A
Other languages
English (en)
Inventor
Frank Greenway
Alexander Mclellan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Origin Biomedicinals Inc
Louisiana State University
Original Assignee
Origin Biomedicinals Inc
Louisiana State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Origin Biomedicinals Inc, Louisiana State University filed Critical Origin Biomedicinals Inc
Publication of AU2008213772A1 publication Critical patent/AU2008213772A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
AU2008213772A 2007-02-06 2008-02-06 Composition comprising terpene compounds and methods for inhibiting nerve transmission Abandoned AU2008213772A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89964207P 2007-02-06 2007-02-06
US60/899,642 2007-02-06
PCT/CA2008/000236 WO2008095297A1 (en) 2007-02-06 2008-02-06 Composition comprising terpene compounds and methods for inhibiting nerve transmission

Publications (1)

Publication Number Publication Date
AU2008213772A1 true AU2008213772A1 (en) 2008-08-14

Family

ID=39681217

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008213772A Abandoned AU2008213772A1 (en) 2007-02-06 2008-02-06 Composition comprising terpene compounds and methods for inhibiting nerve transmission

Country Status (9)

Country Link
US (2) US9999601B2 (enExample)
EP (1) EP2142182B1 (enExample)
JP (2) JP5933164B2 (enExample)
KR (2) KR20150046328A (enExample)
CN (2) CN105581999A (enExample)
AU (1) AU2008213772A1 (enExample)
CA (1) CA2676139C (enExample)
HK (1) HK1224231A1 (enExample)
WO (1) WO2008095297A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105581999A (zh) 2007-02-06 2016-05-18 安元有限公司 用于抑制神经传导的包括萜烯化合物的组合物以及方法
WO2008112641A2 (en) 2007-03-09 2008-09-18 New York University Methods and compositions for treating thalamocortical dysrhythmia
CA2732784C (en) * 2008-08-13 2018-09-18 Neuroquest Inc. Compositions comprising terpene compounds for treating negative sensory phenomena
CA2811241A1 (en) * 2010-09-14 2012-03-22 Neuroquest Inc. Terpenoid analogues and uses thereof for treating neurological conditions
WO2012053003A1 (en) * 2010-10-18 2012-04-26 Anil Kumar Gupta A novel herbal oil for controlling blood sugar without risk of hypoglycemea
CA2841972A1 (en) * 2011-07-14 2013-01-17 Neuroquest Inc. Terpene analogues and uses thereof for treating neurological conditions
US9228727B2 (en) 2012-04-05 2016-01-05 Michael W. May Lighting assembly
WO2013168090A1 (en) 2012-05-07 2013-11-14 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Researc Organization (Aro) (Volcanii Center). Geranium oil and constituents thereof for treatment of neurodegenerative diseases
WO2014051113A1 (ja) 2012-09-28 2014-04-03 株式会社資生堂 Ｖｅｇｆｃ産生促進剤
WO2014187946A1 (en) * 2013-05-24 2014-11-27 Nestec S.A. Treatment or prevention of autism disorders using menthol, linalool and/or icilin
US10493042B2 (en) 2013-08-01 2019-12-03 University-Industry Cooperation Group Of Kyung Hee University Method for preventing or treating diabetes mellitus, and method for screening for diabetes mellitus therapeutic agent
WO2015016682A1 (ko) 2013-08-01 2015-02-05 경희대학교 산학협력단 당뇨병 예방 또는 치료용 약학적 조성물, 당뇨병 예방 또는 치료 방법, 및 당뇨병 치료제 스크리닝 방법
KR102250582B1 (ko) 2018-05-11 2021-05-12 고려대학교 산학협력단 별아교세포 특이적 수동전도도 억제약물의 스크리닝 시스템 및 이의 활용

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555333A (en) 1975-05-29 1979-11-07 Bush Boake Allen Ltd Perfumery compositions comprising hydroxy- or alkoxy-substituted c9 alkanals alkanols and esters
NZ190416A (en) 1978-05-16 1981-05-29 Unilever Ltd Deodorant product
CH673931A5 (enExample) 1986-05-08 1990-04-30 R & C Products Pty Ltd
DE3779500T2 (de) 1986-06-10 1993-01-21 Chiesi Farma Spa Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
DE3725248A1 (de) 1987-07-30 1989-02-09 Henkel Kgaa Antimikrobiell wirksame, aromatisierte zubereitungen
US5770738A (en) 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
US5260313A (en) * 1992-03-12 1993-11-09 National Pain Institute, Inc. Diagnosis and treatment of various neuralgias
US6248307B1 (en) 1999-04-14 2001-06-19 Standard Homeopathic Company Compositions and treatment for alleviation of symptoms associated with menopause
EP1424071B1 (en) 2001-08-08 2008-08-20 Shiseido Company Limited Perfume compositions
US20030092636A1 (en) 2001-11-06 2003-05-15 Silberstein Stephen D. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
AU2002360517A1 (en) * 2001-12-07 2003-06-23 Ximed Group Plc Respiratory infection prevention and treatment with terpene-containing compositions
US20030224072A1 (en) * 2002-06-03 2003-12-04 Frome Bruce Marshall Topical and oral administration of a composition containing Pelargonium Graveolens for diagnosis and treatment of various neuralgias and other conditions
US7943166B2 (en) * 2003-04-10 2011-05-17 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
US20050025823A1 (en) * 2003-07-29 2005-02-03 Fong Andy A.T. Methods of use of herbal compositions
US20050112183A1 (en) 2003-11-25 2005-05-26 Galer Bradley S. Compositions and methods for treating neuropathic sensory loss
US20060004050A1 (en) 2004-07-02 2006-01-05 Speicher Brian T Compositions and methods for the prevention or treatment of pain and other nervous system disorders
WO2006105481A1 (en) * 2005-03-30 2006-10-05 Neurogesx, Inc. Low-concentration capsaicin patch and methods for treating neuropathic pain
US20070203080A1 (en) 2006-02-15 2007-08-30 The Regents Of The University Of California New Drug Delivery System for Crossing the Blood Brain Barrier
WO2008108825A2 (en) 2006-10-10 2008-09-12 Burnham Institute For Medical Research Neuroprotective compositions and methods
KR20090082507A (ko) * 2006-11-20 2009-07-30 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 통증 및 소양증 치료용 방법, 조성물 및 키트
CN105581999A (zh) * 2007-02-06 2016-05-18 安元有限公司 用于抑制神经传导的包括萜烯化合物的组合物以及方法
US8236239B2 (en) 2007-11-16 2012-08-07 Bernstein Eric F Sterilizing compositions comprising phosphors for converting electromagnetic radiation to UVC radiation and methods for using the same
GB2460214A (en) 2008-03-20 2009-11-25 Hexcel Composites Ltd Prepregs for use in making laminates of reduced porosity
FR2934925B1 (fr) * 2008-08-06 2011-02-25 Soitec Silicon On Insulator Procede de fabrication d'une structure comprernant une etape d'implantations d'ions pour stabiliser l'interface de collage.
CA2732784C (en) 2008-08-13 2018-09-18 Neuroquest Inc. Compositions comprising terpene compounds for treating negative sensory phenomena
WO2010057295A1 (en) 2008-11-18 2010-05-27 Origin Biomed Inc. Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
CA2811241A1 (en) 2010-09-14 2012-03-22 Neuroquest Inc. Terpenoid analogues and uses thereof for treating neurological conditions
CA2841972A1 (en) 2011-07-14 2013-01-17 Neuroquest Inc. Terpene analogues and uses thereof for treating neurological conditions

Also Published As

Publication number Publication date
CN105581999A (zh) 2016-05-18
WO2008095297A1 (en) 2008-08-14
HK1224231A1 (zh) 2017-08-18
JP2016121169A (ja) 2016-07-07
KR20100014922A (ko) 2010-02-11
US9999601B2 (en) 2018-06-19
JP2010518030A (ja) 2010-05-27
EP2142182A4 (en) 2010-03-03
CA2676139A1 (en) 2008-08-14
US20180207110A1 (en) 2018-07-26
JP6144785B2 (ja) 2017-06-07
EP2142182A1 (en) 2010-01-13
JP5933164B2 (ja) 2016-06-08
CN101677973A (zh) 2010-03-24
EP2142182B1 (en) 2017-09-27
KR20150046328A (ko) 2015-04-29
KR101580857B1 (ko) 2015-12-30
CA2676139C (en) 2016-04-26
US20110257255A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
CA2676139C (en) Composition comprising terpene compounds and methods for inhibiting nerve transmission
US20160317466A1 (en) Compositions comprising terpene compounds for treating negative sensory phenomena
BR112020017023A2 (pt) terapêutica à base de cannabis e método de uso
JP2021525709A (ja) 自閉症スペクトラム障害の治療のためのカンナビスベースの組成物
WO2022115796A1 (en) Compositions and methods for treating neurological conditions
Venâncio et al. Ocimum basilicum leaf essential oil and (-)-linalool reduce orofacial nociception in rodents: a behavioral and electrophysiological approach
CA2743967A1 (en) Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
US20030224072A1 (en) Topical and oral administration of a composition containing Pelargonium Graveolens for diagnosis and treatment of various neuralgias and other conditions
US20220168235A1 (en) Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia
US20240131038A1 (en) Anti-inflammatory compositions comprising cannabidiol, delta-9-tetrahydrocannabinol and linalool
CA2788493A1 (en) Composition and method for the treatment of neuropathic pain
Schell Sceletium tortuosum and mesembrine: a potential alternative treatment for depression
McLellan et al. Compositions comprising terpene compounds for treating negative sensory phenomena
Huntsman et al. Cannabis for pediatric and adult epilepsy
McKinley Marijuana, a Journey through the Endocannabinoid System: Unmasking the Paradoxical
Mathew An Unexplored Under-recognized
AU2024315631A1 (en) Composition for use in treatment and/or prevention of chronic musculoskeletal pain including chronic low back pain, chronic non-specific low back pain, osteoarthritis or other chronic musculoskeletal pain conditions comprising delta-9-tetrahydrocannabinol and terpenes
WO2021151185A1 (pt) Fitoterápico, fitofármaco e uso de ambos
Dallal Drug-refractory depression: the addition of lithium to fluoxetine or desipramine

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: ADD THE CO-APPLICANT BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE

MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period